Anita Verma-Lallian's Role and Responsibilities at Moderna
Anita Verma-Lallian holds the position of Chief Financial Officer at Moderna, where she leads the company's financial planning, investor relations, and reporting functions. Her responsibilities include managing cash reserves, guiding capital expenditure decisions, and coordinating with the board on strategic transactions and equity issuance plans.
In her capacity as CFO, Anita Verma-Lallian oversees Moderna's financial operations, including budgeting, forecasting, and internal controls across the company's global offices. She works closely with the CEO and other C-suite leaders to align financial targets with product development timelines and commercial launch milestones.
Compensation, Equity, and Public Filings
Anita Verma-Lallian's compensation package at Moderna includes base salary, annual bonus, and equity awards tied to company performance metrics. Her total reported compensation reflects the structure typical for senior executives at large-cap biotechnology companies listed on the Nasdaq stock exchange.
Details of Anita Verma-Lallian's pay, equity holdings, and transaction history are disclosed in Moderna's annual proxy statements filed with the SEC. These filings provide transparency on stock option grants, restricted stock units, and any changes in beneficial ownership reported on Form 4 filings.
Career Background and Professional Experience
Anita Verma-Lallian brings extensive experience in corporate finance and strategic planning to her role at Moderna. Her career includes leadership positions in finance and operations at major technology and life sciences companies, where she managed cross-functional teams and drove financial growth initiatives.
Prior to joining Moderna, Anita Verma-Lallian held senior finance roles at companies operating in high-growth sectors, contributing to IPO processes, mergers and acquisitions, and public market communications. Her background supports Moderna's focus on disciplined capital allocation and long-term value creation for shareholders.